Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SPNE message board posts where the ticker symbol SPNE has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SPNE SEC Filings

Filings Format Description Filing Date File/Film Number
424B5  Documents Prospectus [Rule 424(b)(5)]
Acc-no: 0001193125-18-297660 (33 Act)  Size: 503 KB
2018-10-11 333-213089
181118552
8-K  Documents Current report, items 1.01, 8.01, and 9.01
Acc-no: 0001193125-18-297658 (34 Act)  Size: 305 KB
2018-10-11 001-36905
181118539
424B5  Documents Prospectus [Rule 424(b)(5)]
Acc-no: 0001193125-18-296861 (33 Act)  Size: 506 KB
2018-10-10 333-213089
181116346
8-K  Documents Current report, items 8.01 and 9.01
Acc-no: 0001193125-18-296848 (34 Act)  Size: 158 KB
2018-10-10 001-36905
181116276
8-K/A  Documents [Amend] Current report, items 2.02 and 9.01
Acc-no: 0001637761-18-000138 (34 Act)  Size: 415 KB
2018-10-02 001-36905
181100464
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001637761-18-000136 (34 Act)  Size: 76 KB
2018-10-02 001-36905
181099495
8-K  Documents Current report, item 8.01
Acc-no: 0001637761-18-000133 (34 Act)  Size: 29 KB
2018-09-04 001-36905
181052730
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001637761-18-000131 Size: 4 KB
2018-08-31
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001637761-18-000129 Size: 8 KB
2018-08-29
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001637761-18-000127 Size: 9 KB
2018-08-03
More SPNE SEC Filings


Related news from
Thu, 11 Oct 2018
12:57:19 +0000
SeaSpine Prices Public Offering of Common Stock
SeaSpine Holdings Corporation (SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced underwritten public offering of 3,250,000 shares of its common stock at a public offering price of $15.50 per share. The gross proceeds to SeaSpine, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $50.4 million. Wells Fargo Securities, LLC, Piper Jaffray & Co. and Cantor Fitzgerald & Co. are acting as joint book-running managers and BTIG, LLC is acting as lead manager for the offering.
Wed, 10 Oct 2018
20:24:05 +0000
SeaSpine Commences Public Offering of Common Stock
SeaSpine Holdings Corporation (SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by SeaSpine. Wells Fargo Securities, LLC, Piper Jaffray & Co. and Cantor Fitzgerald & Co. are acting as joint book-running managers and BTIG, LLC is acting as lead manager for the offering.
Tue, 09 Oct 2018
12:49:13 +0000
Is SeaSpine Holdings Corporation (NASDAQ:SPNE) An Industry Laggard Or Leader?
SeaSpine Holdings Corporation (NASDAQ:SPNE), a US$263m small-cap, operates in the healthcare industry, which faces more complex and interdependent challenges, requiring multi-pronged, collaborative, and technology-enabled business models. Healthcare analysts are forecasting<div><a class="permalink" href="https://simplywall.st/news/yahoo-post/is-seaspine-holdings-corporation-nasdaqspne-an-industry-laggard-or-leader/">Read More...</a></div>
Tue, 02 Oct 2018
12:15:00 +0000
SeaSpine Announces Preliminary Results for Third Quarter 2018
SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the three-months ended September 30, 2018. Cash and cash equivalents at September 30, 2018 are expected to be approximately $11.5 million.  The Company borrowed $3.0 million of cash under its credit facility during the third quarter of 2018 and had $7.3 million of outstanding borrowings under the credit facility as of September 30, 2018. The Company has not sold any shares of its common stock under its $50 million “at the market” equity offering program.
Fri, 28 Sep 2018
20:05:00 +0000
SeaSpine to Present at Upcoming Investor Conferences
SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to present at two upcoming investor conferences. SeaSpine management is scheduled to present at the Ladenburg Thalmann 2018 Healthcare Conference in New York, NY on Tuesday, October 2 at 3:00pm ET. SeaSpine management is also scheduled to present at the Cantor Global Healthcare Conference in New York, NY on Wednesday, October 3 at 9:10am ET.
Wed, 26 Sep 2018
12:15:00 +0000
SeaSpine Announces Launch of Regatta™ Lateral System
SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the launch of the Regatta™ Lateral System, featuring NanoMetalene® technology. Regatta is a comprehensive, minimally invasive lateral interbody fusion system designed to efficiently and reproducibly treat the spine through indirect decompression and the restoration of sagittal alignment. The Regatta lateral retractor and the EMG nerve detection dilators allow for customizable access with minimal tissue disruption through the psoas, while also providing the visualization necessary to effectively perform the procedure.
Tue, 28 Aug 2018
20:05:00 +0000
SeaSpine to Participate in the 13th Annual Wells Fargo Securities Healthcare Conference
SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the Company plans to participate in the 13th Annual Wells Fargo Securities Healthcare Conference at the Westin Copley Place in Boston, Massachusetts on Wednesday, September 5th, 2018 at 8:00 am ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company’s website at www.seaspine.com. SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders.
Sun, 05 Aug 2018
17:19:03 +0000
Edited Transcript of SPNE earnings conference call or presentation 30-Jul-18 8:30pm GMT
Q2 2018 SeaSpine Holdings Corp Earnings Call
Fri, 03 Aug 2018
20:05:00 +0000
SeaSpine Reports Granting of Inducement Awards
SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to nine non-executive employees.
Mon, 30 Jul 2018
20:05:00 +0000
SeaSpine Reports Second Quarter 2018 Financial Results
CARLSBAD, Calif., July 30, 2018-- SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results ...
Mon, 30 Jul 2018
18:30:00 +0000
SeaSpine Holdings Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 30, 2018 / SeaSpine Holdings Corp. (NASDAQ: SPNE ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 30, 2018 at 4:30 PM Eastern Time. ...
Wed, 27 Jun 2018
12:58:58 +0000
Is It The Right Time To Buy SeaSpine Holdings Corporation (NASDAQ:SPNE)?
SeaSpine Holdings Corporation (NASDAQ:SPNE), a medical equipment company based in United States, received a lot of attention from a substantial price increase on the NasdaqGS over the last few months.Read More...
Thu, 07 Jun 2018
16:19:35 +0000
As Spinal Stocks Climb Toward Yearly Highs, There’s Still Room for Upside
Cantor Fitzgerald is starting coverage on biotech companies in the spinal segment, a market that the investment house thinks has a $9-billion global market opportunity. Globus Medical Inc (NYSE:GMED) earned an “Overweight” rating from Cantor Fitzgerald. GMED stock has a market cap of $5.41 billion and is valued at 10.6 times its book value per share.
Tue, 08 May 2018
17:40:47 +0000
Edited Transcript of SPNE earnings conference call or presentation 3-May-18 8:30pm GMT
Q1 2018 SeaSpine Holdings Corp Earnings Call
Mon, 05 Mar 2018
17:10:50 +0000
Edited Transcript of SPNE earnings conference call or presentation 28-Feb-18 9:30pm GMT
Q4 2017 SeaSpine Holdings Corp Earnings Call



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I have been a VF subscriber for one year and have found the members here generally to be informed, intelligent, articulate people of good will. The knowledge I've gathered has been well worth the price of tuition, and the subscription fee has been repaid many-fold in investment gains." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards